FDA Inspection
Trinity Health Ann ArborTrinity Health Ann Arbor – FDA Inspection, Feb 13, 2012
Record Details
This FDA Inspection record concerns Trinity Health Ann Arbor, with an inspection on February 13, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Trinity Health Ann Arbor
- Inspection Date
- February 13, 2012
- Product Type
- Biologics
View Company Profile
ID · b42742d0-b5cd-46d0-97a8-13951aed8f5e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 768613
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Trinity Health Ann Arbor
5| Date | Classification | Office | Project area |
|---|---|---|---|
| November 21, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 5, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 7, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 20, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 12, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Trinity Health Ann Arbor
- FDA Inspection 1256280 - 2024-11-21
- FDA Inspection 1094432 - 2019-06-05
- FDA Inspection 994011 - 2016-12-07
- FDA Inspection 867201 - 2014-02-20
- FDA Inspection 637953 - 2010-01-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.